Mark Schreyer

Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors

A. Drilon, A. Schram, J. Hechtman, 2019, JCO precision oncology.

Sustained imaging response and hearing preservation with low-dose bevacizumab in sporadic vestibular schwannoma.

M. Hagiwara, M. Karajannis, S. Haque, 2019, Neuro-oncology.

Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases

A. Drilon, M. Kris, N. Rekhtman, 2019, JCO precision oncology.